[ad_1]
The pharmaceutical company Pfizer Inc. said that the experimental vaccine it had developed showed more than 90% effectiveness in preventing coronavirus infection, according to initial data from a large study, which could be an important step in the fight against the virus. pandemic, Reuters reported.
Pfizer and its German partner BioNTech SE are the first drug manufacturers to show successful data from a large-scale clinical trial of a coronavirus vaccine. The companies said they had not encountered serious concerns about the vaccine’s safety so far and expected to apply for permission for emergency use in the United States later this month.
If allowed, the amount of vaccine doses initially will be limited. Many questions remain, including how long such a vaccine will provide protection. However, the news gives hope that other vaccines in development against the new coronavirus may also be effective, BNR reported.
“Today is a great day for science and humanity,” said Albert Burla, President and CEO of Pfizer. “We are achieving this critical milestone in our vaccine development program at a time when the world needs it most, as infection levels are setting new records, hospitals are approaching overcapacity and economies are trying to reopen, “he added. the.
[ad_2]
